Cerca
Ara mostrant els elements 1-10 de 14
Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
(Wiley, 2018)
Aims: To assess the cost‐effectiveness of alternative smoking cessation scenarios from the perspective of the Spanish National Health Service (NHS). Design: We used the European study on Quantifying ...
Estimates of costs for modelling return on investment from smoking cessation interventions
(Wiley, 2018)
Background and aims: Modelling return on investment (ROI) from smoking cessation interventions requires estimates of their costs and benefits. This paper describes a standardized method developed to ...
EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control
(BMJ Publishing Group, 2014-11-24)
Introduction: Tobacco smoking claims 700 000 lives
every year in Europe and the cost of tobacco smoking in
the EU is estimated between €98 and €130 billion
annually; direct medical care costs and ...
Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial
(BMC, 2011-08-22)
Background
Low back pain (LBP), with high incidence and prevalence rate, is one of the most common reasons to consult the health system and is responsible for a significant amount of sick leave, leading ...
Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial
(BMC, 2011-10-19)
Background: A high percentage of cervical cancer cases have not undergone cytological tests within 10 years
prior to diagnosis. Different population interventions could improve coverage in the public ...
Economic impact of HIV/AIDS: a systematic review in five European countries
(SpringerOpen, 2014-09-16)
The HIV/AIDS disease represent a priority for all health authorities in all countries and it also represents serious added socioeconomic problems for societies over the world. The aim of this paper is ...
El papel de la evaluación económica en las Comisiones Farmacoterapéuticas de dos hospitales de tercer nivel
(Sociedad Española de Farmacia Hospitalaria, 2018)
Cuestiones controvertidas en evaluación económica (II): medidas de resultado en salud de las intervenciones sanitarias
(Ministerio de Sanidad y Consumo, 2015-03)
En este segundo artículo, de una serie de tres, debatiremos, empleando la técnica Metaplan, sobre cuestiones controvertidas de las medidas de resultado en salud en la evaluación económica de intervenciones ...
Costes sanitarios de las enfermedades profesionales: análisis de una serie de pacientes de un hospital público
(Associació Catalana de Salut Laboral, 2019)
El infra-reconocimiento secular de las enfermedades profesionales (EP) en España provoca un intercambio de pacientes y recursos entre el Sistema Nacional de Salud y el de Seguridad Social. Se estimaron ...
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: The Modelling Algorithm Pathways in Guidelines (MAPGuide) project
(NIHR Journals Library, 2013-12)
Background: National Institute for Health and Care Excellence (NICE) clinical guidelines (CGs) make recommendations across large, complex care pathways for broad groups of patients. They rely on ...